🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
New study shows baldness and prostate cancer may be interrelated

Singapore - A recent study observed a connection between male-pattern baldness, when it occurs at a young age, and the s...

January 25, 2018 | Thursday | News
XtalPi secures $15 M funding

Computation-driven pharmaceutical technology company XtalPi Inc. has closed a Series B funding round of $15 million led ...

January 24, 2018 | Wednesday | News
OBI Pharma receives FDA nod for Phase I study of its cancer drug

Taiwan-based biopharma company OBI Pharma announced that it has received the US FDA nod for an investigational new drug ...

January 18, 2018 | Thursday | News
Forty Seven collaborates with Merck KGaA on a novel combination for ovarian cancer

Singapore - Forty Seven, a US based clinical-stage company focused on developing the next generation of transformational...

January 16, 2018 | Tuesday | News
FDA approves first treatment for breast cancer with a certain inherited genetic mutation

Singapore - The U.S. Food and Drug Administration expanded the approved use of Lynparza (olaparib tablets) to include th...

January 15, 2018 | Monday | News
Telix Pharmaceuticals establishes Japanese Subsidiary, Appoints Key Executives

Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic...

January 15, 2018 | Monday | News
BerGenBio meets first efficacy endpoint in phase II trial evaluating BGB324

A clinical –stage biopharmaceutical company BerGenBio ASA has announced that the first efficacy endpoint has been ...

January 10, 2018 | Wednesday | News
Intec Pharma acknowledged with patent

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordio...

January 8, 2018 | Monday | Regulatory
Pfizer to launch a new venture fund to invest in neuroscience research projects

The U.S. pharmaceutical company, Pfizer has announced that it is abandoning research to find new drugs aimed at treating...

January 8, 2018 | Monday | News
Drug for diabetes type 2 shows potential in treating Alzheimer’s

According to new research published in the Brain Research Journal, a drug developed for type 2 diabetes could possibly b...

January 4, 2018 | Thursday | News
Biocon & Mylan's biosimilar gets Brazilian approval

The biosimilar trastuzumab has been approved by ANVISA, the Brazilian regulatory agency. Co-developed by Biocon and...

December 29, 2017 | Friday | News
FDA approves drug to treat dangerously low blood pressure

Singapore - The U.S. Food and Drug Administration approved Giapreza (angiotensin II) injection for intravenous infusion ...

December 27, 2017 | Wednesday | News
Dr. Reddy's launches Melphalan Hydrochloride for Injection in the U.S. Market

Dr. Reddy’s Laboratories Ltd has announced that it has launched Melphalan Hydrochloride for Injection which is a t...

December 27, 2017 | Wednesday | News
CANbridge submits investigational new drug application for cancer treatment

CANbridge Life Sciences is a bio-pharmaceutical company accelerating development and commercialization of specialty heal...

December 27, 2017 | Wednesday | News
Otsuka collaborates with X-Chem for new drug compounds

US based X-Chem, Inc. and Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd. headquartered in To...

December 26, 2017 | Tuesday | News
Adaptive Phase II Study of BAN2401 in Early Alzheimer’s Disease Continues toward 18-Month Endpoint

Eisai Co., Ltd. and Biogen Inc. has announced that an Independent Data Monitoring Committee has determined that BAN2401,...

December 22, 2017 | Friday | News
Confo Therapeutics enters into collaboration with Roche

Drug Discovery company, Confo Therapeutics has announced that it has entered into a research collaboration and license a...

December 20, 2017 | Wednesday | News
Researchers show patients' own immune cells can fight deadly cancers

Singapore - Scientists have taken a significant step forward in efforts to harness our own white blood cells to fight de...

December 15, 2017 | Friday | News